9 /100
LOW RISK
Score updated Jul 13, 2026

NOV — NOV Inc. Dilution Risk Tracker

Track NOV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NOV — Get alerts when the score changes →

As of July 13, 2026, NOV Inc. (NOV) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. NOV Inc. has a market capitalization of $7.16B, 358.89M shares outstanding, 464 institutional holders tracked. Key dilution vectors include approximately 94 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
18
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NOV.
🔔 Track NOV — Get forecast alerts →

💹 Market Data

Market Cap$7.16B
Shares Outstanding358.89M
Float356.91M
Cash$1.34B
Debt$1.70B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 15.6% shares (2026Q1 vs prior)
464 institutional holders · 429.08M shares
#1 First Eagle Investment Management, LLC 72.82M shares
#2 BlackRock, Inc. 37.82M shares
#3 PZENA INVESTMENT MANAGEMENT LLC 37.54M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest31.56M
Days to Cover5.3
% of Float8.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

3 FORM3 Apr 08, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Feb 25, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for NOV Shareholders

NOV Inc. (NOV) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for NOV shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NOV in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NOV alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NOV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NOV — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

LBTYA LBTYK AER AIG BABA

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NOV
📊 NOV FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NOV Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.